There are 2789 resources available
1802MO - Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort
Presenter: Letizia Gnetti
Session: Mini oral session - Basic science
Resources:
Abstract
Slides
Webcast
723MO - Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study
Presenter: Ignace Vergote
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
724MO - Balstilimab (anti-PD-1) in combination with zalifrelimab (anti-CTLA-4): Final results from a phase II study in patients (pts) with recurrent/metastatic (R/M) cervical cancer (CC)
Presenter: David O'Malley
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
725MO - Phase I study of the combination of the dual RAF/MEK inhibitor VS-6766 and the FAK inhibitor defactinib: Results of efficacy in low grade serous ovarian cancer
Presenter: Susana Banerjee
Session: Mini oral session - Gynaecological cancers
Resources:
Abstract
Slides
Webcast
576MO - Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of <sup>177</sup>Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Presenter: Karim Fizazi
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
LBA26 - Darolutamide maintenance in metastatic castration resistant prostate cancer (mCRPC) previously treated with novel hormonal agents (NHA) and non-progressive disease after subsequent treatment with a taxane: A randomized double-blind placebo-controlled phase II trial (SAKK 08/16)
Presenter: Richard Cathomas
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
578MO - Phase Ib/II study of sabizabulin (VERU-111), an androgen receptor transport disruptor, in men with metastatic castration resistant prostate cancer (mCRPC) who failed an androgen receptor targeting agent (ARTA)
Presenter: Mark Markowski
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
828MO - Exonic mutation profile of primary gastrointestinal diffuse large B-cell lymphoma
Presenter: Shan-Shan Li
Session: Mini oral session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
829MO - A gene signature to predict risk of transformation in patients with follicular lymphoma
Presenter: Ismael Fernandez-Miranda
Session: Mini oral session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
830MO - Integrated driver mutations profile of Chinese NK/T cell lymphoma
Presenter: Ting-zhi Liu
Session: Mini oral session - Haematological malignancies
Resources:
Abstract
Slides
Webcast